TFF3 and cancer: Although systematic Cytosponge-TFF3 testing for individuals on medication for reflux incurs higher costs per person than usual care, and involves additional diagnostic endoscopy in a minority, Cytosponge-TFF3 also generates additional quality-adjusted life-years due to earlier cancer diagnosis and curative treatment.